Phillip Sharp

Track

Insider profile

Currently holds positions in Alnylam Pharmaceuticals Inc, Syros Pharmaceuticals Inc and Vir Biotechnology Inc

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Alnylam Pharmaceuticals Inc June 1, 2002 -
Independent Director Syros Pharmaceuticals Inc Dec. 1, 2012 -
Independent Director Vir Biotechnology Inc Jan. 1, 2017 -
Phillip Sharp's trades of Alnylam Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-30 2025-05-30
PrS Proposed sale
44,377
74.26
US$4,744,673 		44,377 74.26 US$4,744,673
2025-01-24 2025-01-23
PlS Planned sale
29,747 -41.9%
258.53
US$3,219,526 		29,747 -41.9% 258.53 US$3,219,526
2025-01-23 2025-01-23
PrS Proposed sale
31,108
47.43
US$3,319,341 		31,108 47.43 US$3,319,341
2024-07-10 2024-07-10
PrS Proposed sale
25,897
9.30
US$240,842 		25,897 9.30 US$240,842
2024-03-01 2024-02-29
PlS Planned sale
516 -100.0%
156.54
US$80,775 		516 -100.0% 156.54 US$80,775
2024-03-01 2024-02-29
PlS Planned sale
101 -16.4%
154.07
US$15,561 		101 -16.4% 154.07 US$15,561
2024-03-01 2024-02-29
PlS Planned sale
1,906 -75.5%
153.62
US$292,800 		1,906 -75.5% 153.62 US$292,800
2024-03-01 2024-02-29
PlS Planned sale
915 -26.6%
152.40
US$139,446 		915 -26.6% 152.40 US$139,446
2024-03-01 2024-02-29
PlS Planned sale
13,557 -79.8%
151.43
US$2,052,937 		13,557 -79.8% 151.43 US$2,052,937
2024-03-01 2024-02-29
PlS Planned sale
13,005 -43.4%
150.60
US$1,958,553 		13,005 -43.4% 150.60 US$1,958,553
2024-02-29 2024-02-29
PrS Proposed sale
30,000
156.59
US$4,697,700 		30,000 156.59 US$4,697,700
2022-08-17 2022-08-15
PlS Planned sale
715 -100.0%
232.81
US$166,459 		715 -100.0% 232.81 US$166,459
2022-08-17 2022-08-15
PlS Planned sale
3,853 -84.3%
231.65
US$892,547 		3,853 -84.3% 231.65 US$892,547
2022-08-17 2022-08-15
PlS Planned sale
16,186 -78.0%
230.71
US$3,734,272 		16,186 -78.0% 230.71 US$3,734,272
2022-08-17 2022-08-15
PlS Planned sale
11,600 -35.9%
229.93
US$2,667,188 		11,600 -35.9% 229.93 US$2,667,188
2022-08-17 2022-08-15
PlS Planned sale
1,218 -3.6%
228.33
US$278,106 		1,218 -3.6% 228.33 US$278,106
2022-08-17 2022-08-15
PlS Planned sale
98 -0.3%
226.16
US$22,164 		98 -0.3% 226.16 US$22,164
2022-02-11 2022-02-09
PlS Planned sale
30,000 -100.0%
150.00
US$4,500,000 		30,000 -100.0% 150.00 US$4,500,000
2020-11-30 2020-11-25
PlS Planned sale
645 -0.3%
127.44
US$82,199 		645 -0.3% 127.44 US$82,199
2020-11-30 2020-11-25
PlS Planned sale
2,117 -0.9%
126.16
US$267,081 		2,117 -0.9% 126.16 US$267,081
2020-11-30 2020-11-25
PlS Planned sale
15,715 -6.2%
125.05
US$1,965,161 		15,715 -6.2% 125.05 US$1,965,161
2020-11-30 2020-11-25
PlS Planned sale
11,523 -4.3%
124.30
US$1,432,309 		11,523 -4.3% 124.30 US$1,432,309
2020-02-13 2020-02-12
PlS Planned sale
30,000 -11.3%
130.00
US$3,900,000 		30,000 -11.3% 130.00 US$3,900,000
2019-11-20 2019-11-18
PlS Planned sale
810 -0.3%
92.66
US$75,055 		810 -0.3% 92.66 US$75,055
2019-11-20 2019-11-18
PlS Planned sale
8,631 -3.5%
91.97
US$793,793 		8,631 -3.5% 91.97 US$793,793
2019-11-20 2019-11-18
PlS Planned sale
5,559 -2.2%
91.17
US$506,814 		5,559 -2.2% 91.17 US$506,814
2019-04-17 2019-04-15
PlS Planned sale
600 -0.3%
91.40
US$54,840 		600 -0.3% 91.40 US$54,840
2019-04-17 2019-04-15
PlS Planned sale
400 -0.2%
89.97
US$35,988 		400 -0.2% 89.97 US$35,988
2019-04-17 2019-04-15
PlS Planned sale
2,200 -0.9%
89.03
US$195,866 		2,200 -0.9% 89.03 US$195,866
2019-04-17 2019-04-15
PlS Planned sale
11,800 -4.7%
87.86
US$1,036,748 		11,800 -4.7% 87.86 US$1,036,748
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
100,000 -17.3%
59.12
US$5,911,690 		100,000 -17.3% 59.12 US$5,911,690
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
100,000 -14.7%
58.53
US$5,853,470 		100,000 -14.7% 58.53 US$5,853,470
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
70,000 -9.4%
58.70
US$4,108,979 		70,000 -9.4% 58.70 US$4,108,979
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
24,100 -3.1%
58.41
US$1,407,669 		24,100 -3.1% 58.41 US$1,407,669
2004-05-14 2004-05-13
US Biogen Inc (BIIB)
S Sale
65,000 -100.0%
58.00
US$3,770,000 		65,000 -100.0% 58.00 US$3,770,000
2004-05-05 2004-05-05
US Biogen Inc (BIIB)
S Sale
50,000 -6.1%
59.00
US$2,950,000 		50,000 -6.1% 59.00 US$2,950,000
2004-05-05 2004-05-04
US Biogen Inc (BIIB)
S Sale
5,900 -0.7%
58.90
US$347,510 		5,900 -0.7% 58.90 US$347,510
2004-05-05 2004-05-04
US Biogen Inc (BIIB)
S Sale
23,000 -16.7%
59.00
US$1,357,000 		23,000 -16.7% 59.00 US$1,357,000